101:, one of the world's leading specialists in the manufacture of laboratory instruments. Within a short time, Dekkers implemented a complete corporate reorganization and became President and CEO in 2002. In this role, he initiated further extensive restructuring measures, divesting various organizational units and strengthening the company's core business by means of targeted acquisitions, including the purchase in 2006 of the laboratory consumables supplier
116:. On 3 June 2014 Bayer AG announced that its Supervisory Board had extended Marijn Dekkers' term as CEO by two years, on expiration of the initial five-year period. Dekkers cited family reasons for extending his contract only until the end of 2016. He left Bayer on 30 April 2016 and was succeeded by Werner Baumann on 1 May 2016.
441:
Is this going to have a big effect on our business model? No, because we did not develop this product for the Indian market, let’s be honest. We developed this product for
Western patients who can afford this product, quite honestly. It is an expensive product, being an oncology
162:"So now, is this going to have a big effect on our business model? No, because we did not develop this product for the Indian market, let's be honest. I mean, you know, we developed this product for Western patients who can afford this product, quite honestly."
521:
452:
181:
I regret that what was a quick response from me within the framework of a panel discussion at the recent FT Pharma conference has come across in a different way as it was meant by myself. It could not be more opposite to what I want and we do at
50:
Dekkers grew up as the youngest of three children of a merchant in the Dutch city of
Tilburg. After attending local schools, St. Aloysius (primary school) and St. Odulphus (Lyceum), in 1976 he began studying
173:
sums up everything that is wrong with the multinational pharmaceutical industry. Bayer is effectively admitting that the drugs they develop are deliberately going to be rationed to the wealthiest patients.
525:
449:
578:
408:
177:
Dekkers replied to this, referring to the decision made by the Indian government, not to protect a patent on
Nexavar and the intellectual property of Bayer. He also said:
546:
140:"Business person of the Year 2015" by the "Finanzen Verlag" publishing group and the readers of its publications "€uro am Sonntag", "€uro" and "Börse online"
655:
113:
272:
126:
In 2017 Dekkers founded
Novalis LifeSciences LLC, an investment and advisory firm for the Life Science industry (www.novalislifesciences.com).
42:
from 2016 to 2019. He is also
Founder and Chairman of Novalis LifeSciences LLC, an investment and advisory firm for the Life Science industry.
565:
394:
650:
296:
598:
79:(GE) in different research departments located in the US and the Netherlands. In 1988, he became Research Director of the GE range of
151:
In 2013 some controversy was sparked during a
Financial Times panel discussion with relation to Bayer's kidney and liver cancer drug
330:
344:
483:"Transcript of Bayer CEO Marjin Dekkers quote at the December 3, 2013 FT Event, regarding India compulsory license of Nexavar"
60:
660:
665:
236:
382:
112:
On 1 January 2010 Dekkers was appointed to the board of Bayer AG and on 1 October 2010 he took over as CEO from
166:
496:
670:
566:
http://www.msfaccess.org/content/msf-response-bayer-ceo-statement-medicines-developed-only-western-patients
522:"Buffering the Pharma Brand: Restoring Reputation, Rebuilding Trust - PANEL | Calendar | FT Live"
409:"Bayer-Chef Dekkers Unternehmer des Jahres - Kaldemorgen Fondsmanager des Jahres - 03.02.15 - BĂ–RSE ONLINE"
98:
56:
497:"Bayer CEO Marijn Dekkers explains: Nexavar cancer drug is for "western patients who can afford it.""
38:
from 2010 to 2016. He was CEO of Thermo Fisher
Scientific Inc. from 2002 to 2009. He was Chairman of
106:
91:
468:
445:
645:
625:
640:
64:
8:
301:
331:"Dr. Marijn E. Dekkers to be new CEO of Bayer from October 1, 2010 | FierceBiotech"
551:
143:"Most Innovative CEO International 2015" by the German industry's "Innovation Award"
306:
102:
599:"Dr. Marijn E. Dekkers to be new CEO of Bayer from October 1, 2010 | FierceBiotech"
76:
212:
456:
345:"Bayer CEO's long goodbye: Dekkers to depart at end of 2016 | FiercePharma"
359:
634:
310:
87:
83:
and subsequently held management positions in various other polymer units.
137:"Manager of the Year 2014" by German business magazine "Manager Magazin"
192:
27:
547:"Pharma drug development only for wealthy countries? - Times of India"
273:"Thermo Fisher CEO Dekkers leaves to head Bayer; Casper appointed CEO"
52:
422:
120:
80:
39:
500:
482:
152:
23:
261:
The
Deformation Behaviour of Glass Beaded-Filled Glassy Polymers
30:) is a Dutch-American former pharmaceutical businessman. He was
583:
94:
Inc.) and took over the management of various business units.
59:. Three years later he began studying chemical technology at
35:
31:
579:"Does Pharma Only Develop Drugs for Those Who Can Pay?"
109:, which employed 30,000 people in six business groups.
63:, where he received his master's degree and PhD in
97:In 2000, he became a director at the Boston-based
632:
105:. After the acquisition, the company renamed as
169:responded to Dekkers' comment, saying that it
383:Geen Nederlander meer in top-tandem Unilever
446:Columbia Journalism Review, January 29, 2014
297:"Thermo Electron, Fisher Scientific in Deal"
450:Videorecording of the panel (19:00 – 19:30)
439:The original quote causing the debate was "
656:Eindhoven University of Technology alumni
395:"Marijn Dekkers ist "Manager des Jahres""
132:
158:He spoke at a conference in 2014, saying
119:Since April 2016 he was the Chairman of
633:
13:
651:Radboud University Nijmegen alumni
191:Dekkers holds both Dutch and U.S.
61:Eindhoven University of Technology
14:
682:
619:
186:
591:
571:
559:
539:
514:
489:
475:
461:
433:
415:
401:
387:
241:Unilever global company website
376:
357:
351:
337:
323:
289:
265:
253:
229:
210:
204:
146:
57:Radboud University in Nijmegen
1:
360:"Bayer's CEO: Werner Baumann"
198:
45:
499:. 2014-01-23. Archived from
469:"Bloomberg's viral misquote"
7:
99:Thermo Electron Corporation
75:In 1985 Dekkers worked for
22:(born 22 September 1957 in
10:
687:
626:Profile at europeanceo.com
213:"CV of Dr. Marijn Dekkers"
16:Dutch-American businessman
70:
661:Dutch chemical engineers
167:Médecins Sans Frontières
123:until 13 november 2019.
107:Thermo Fisher Scientific
86:In 1995, Dekkers joined
666:German chief executives
92:Honeywell International
20:Marijn Emmanuel Dekkers
184:
175:
164:
133:Awards and recognition
603:www.fiercebiotech.com
179:
171:
160:
427:innovationspreis.com
333:. 15 September 2009.
65:chemical engineering
671:People from Tilburg
605:. 15 September 2009
302:The Washington Post
277:www.bizjournals.com
237:"Dr Marijn Dekkers"
552:The Times of India
455:2014-11-11 at the
259:Title of Thesis:
103:Fisher Scientific
678:
614:
613:
611:
610:
595:
589:
588:
575:
569:
563:
557:
556:
543:
537:
536:
534:
533:
524:. Archived from
518:
512:
511:
509:
508:
493:
487:
486:
479:
473:
472:
465:
459:
437:
431:
430:
419:
413:
412:
405:
399:
398:
391:
385:
380:
374:
373:
371:
370:
355:
349:
348:
341:
335:
334:
327:
321:
320:
318:
317:
293:
287:
286:
284:
283:
269:
263:
257:
251:
250:
248:
247:
233:
227:
226:
224:
223:
208:
77:General Electric
686:
685:
681:
680:
679:
677:
676:
675:
631:
630:
622:
617:
608:
606:
597:
596:
592:
577:
576:
572:
564:
560:
545:
544:
540:
531:
529:
520:
519:
515:
506:
504:
495:
494:
490:
481:
480:
476:
467:
466:
462:
457:Wayback Machine
438:
434:
421:
420:
416:
407:
406:
402:
393:
392:
388:
381:
377:
368:
366:
356:
352:
343:
342:
338:
329:
328:
324:
315:
313:
295:
294:
290:
281:
279:
271:
270:
266:
258:
254:
245:
243:
235:
234:
230:
221:
219:
209:
205:
201:
189:
149:
135:
129:
73:
48:
17:
12:
11:
5:
684:
674:
673:
668:
663:
658:
653:
648:
643:
629:
628:
621:
620:External links
618:
616:
615:
590:
570:
558:
538:
513:
488:
474:
460:
432:
414:
400:
386:
375:
350:
336:
322:
288:
264:
252:
228:
202:
200:
197:
188:
185:
148:
145:
134:
131:
114:Werner Wenning
72:
69:
47:
44:
15:
9:
6:
4:
3:
2:
683:
672:
669:
667:
664:
662:
659:
657:
654:
652:
649:
647:
646:Living people
644:
642:
639:
638:
636:
627:
624:
623:
604:
600:
594:
586:
585:
580:
574:
567:
562:
554:
553:
548:
542:
528:on 2014-11-11
527:
523:
517:
503:on 2014-01-24
502:
498:
492:
485:. 2014-02-07.
484:
478:
470:
464:
458:
454:
451:
447:
443:
436:
428:
424:
418:
410:
404:
396:
390:
384:
379:
365:
364:www.bayer.com
361:
354:
346:
340:
332:
326:
312:
308:
304:
303:
298:
292:
278:
274:
268:
262:
256:
242:
238:
232:
218:
217:www.bayer.com
214:
207:
203:
196:
194:
187:Personal life
183:
178:
174:
170:
168:
163:
159:
156:
154:
144:
141:
138:
130:
127:
124:
122:
117:
115:
110:
108:
104:
100:
95:
93:
90:(later named
89:
88:Allied Signal
84:
82:
78:
68:
66:
62:
58:
54:
43:
41:
37:
33:
29:
25:
21:
607:. Retrieved
602:
593:
582:
573:
561:
550:
541:
530:. Retrieved
526:the original
516:
505:. Retrieved
501:the original
491:
477:
463:
440:
435:
426:
417:
403:
389:
378:
367:. Retrieved
363:
353:
339:
325:
314:. Retrieved
300:
291:
280:. Retrieved
276:
267:
260:
255:
244:. Retrieved
240:
231:
220:. Retrieved
216:
206:
190:
180:
176:
172:
165:
161:
157:
150:
142:
139:
136:
128:
125:
118:
111:
96:
85:
74:
49:
19:
18:
641:1957 births
358:AG, Bayer.
211:AG, Bayer.
193:citizenship
147:Controversy
28:Netherlands
635:Categories
609:2018-06-06
532:2014-11-20
507:2014-11-22
369:2016-05-02
316:2018-06-06
282:2018-06-06
246:2016-05-02
222:2016-05-02
199:References
46:Early life
311:0190-8286
53:chemistry
453:Archived
442:product.
121:Unilever
81:polymers
40:Unilever
36:Bayer AG
153:Nexavar
55:at the
24:Tilburg
584:Forbes
423:"Home"
309:
182:Bayer.
71:Career
444:" –
307:ISSN
34:of
32:CEO
637::
601:.
581:.
568:.
549:.
448:,
425:.
362:.
305:.
299:.
275:.
239:.
215:.
195:.
155:.
67:.
26:,
612:.
587:.
555:.
535:.
510:.
471:.
429:.
411:.
397:.
372:.
347:.
319:.
285:.
249:.
225:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.